A Phase 1 Study Of Rad1901, A Novel, Oral Selective Estrogen Receptor Degrader, For The Treatment Of Er-Positive Advanced Breast CancerVirginia G. Kaklamani,Peter Kabos,Richard Elledge,W Harb, D Purandare, A O'Neill,Fiona Garner,Aditya BardiaCANCER RESEARCH(2017)引用 0|浏览12暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要